Lung Cancer – Early Detection Saves Lives

May 18, 2026

Lung cancer is one of the most common cancers in the world and unfortunately remains the leading cause of cancer-related deaths globally. According to GLOBOCAN 2020, about 2.2 million new cases of lung cancer were diagnosed worldwide in a single year. In India, around 70,000–75,000 new cases are diagnosed annually, and it ranks among the top three cancers in men.

One of the biggest challenges in lung cancer is that more than 60–70% of patients are diagnosed in advanced stages (Stage 3 or Stage 4). Increasing awareness and promoting early detection can significantly improve survival.

Smoking Is the Biggest Risk Factor — But Not the Only One

Smoking remains the most important risk factor for lung cancer. Studies show that 80–85% of lung cancers in men are linked to smoking, and smokers have 15–30 times higher risk of developing lung cancer compared to non-smokers.

However, in India, nearly 30–40% of lung cancer patients are non-smokers, and among women, a majority may have never smoked.

Several factors contribute to lung cancer in non-smokers, including:

• Passive smoking (second-hand smoke)
• Indoor air pollution from biomass fuel or “chulha” smoke
• Outdoor air pollution
• Occupational exposure to harmful chemicals
• Genetic mutations in cancer cells, such as EGFR mutations, which are more common in Asian populations

Warning Signs That Should Not Be Ignored- People should seek medical advice if they experience any Symptoms of lung cancer such as:

• Persistent cough lasting more than three weeks
• Blood in sputum
• Unexplained weight loss
• Chest pain
• Breathlessness

It is important to remember that early-stage lung cancer may not produce symptoms, which is why screening in high-risk individuals is crucial.

Lung Cancer Screening Can Save Lives

A special test called a Low-Dose CT (LDCT) scan can detect lung cancer at an early stage before symptoms develop, highlighting the importance of cancer screening for early diagnosis and better treatment outcomes.

A special test called Low-Dose CT (LDCT) scan can detect lung cancer at an early stage before symptoms develop.

Screening is recommended for people at high risk, particularly those who:

• Are 50–80 years old
• Are current smokers or have quit smoking within the past 15 years
• Have a smoking history of 15-20 pack-years or more

A pack-year is a way of measuring smoking exposure. For example, smoking ½  pack of cigarettes per day for 2 years equals 1 pack-years.

Lung Cancer in Non-Smokers and Women

In Asia, studies show that 50–60% of lung cancers in women occur in non-smokers. Genetic mutations such as EGFR mutations are found in about 30–40% of Indian lung cancer patients, especially those who have never smoked.

Environmental factors such as air pollution, which the World Health Organisation classifies as a Group 1 carcinogen, also contribute to rising lung cancer cases.

When Is Lung Cancer Curable?

Early-stage lung cancer is often associated with favorable outcomes when diagnosed and treated promptly. Survival rates are significantly higher in the early stages, highlighting the importance of early detection and timely intervention.

• Stage I: Approximately 70–90% 5-year survival rate
• Stage II: Approximately 40–60% 5-year survival rate

With appropriate multidisciplinary treatment, many patients diagnosed at an early stage can achieve long-term survival and, in some cases, complete cure.

Locally Advanced Lung Cancer

Stage 3 lung cancer is called locally advanced disease, meaning the cancer has spread to nearby lymph nodes but not to distant organs. It requires Multimodality treatment with comprehensive cancer care and survival outcomes can be as good as early stage lung cancer.

Treatment Advances in Stage 4 Lung Cancer

Stage 4 lung cancer means the disease has spread to other organs such as the brain, liver, bones, or the other lung.

In the past, chemotherapy alone resulted in an average survival of 8–10 months. However, with modern treatments, outcomes have improved dramatically with the advent of Targeted therapy and immunotherapy. Many patients today can live three to five years or longer.

Personalised Treatments: Targeted Therapy

Modern cancer treatment increasingly focuses on precision medicine. Tumor tissue is tested for specific genetic mutations such as EGFR, ALK, ROS1, BRAF, or MET.

If these mutations are present, patients may benefit from targeted therapy tablets, which specifically attack cancer cells while causing fewer side effects.

For example, in patients with EGFR mutations, the targeted drug osimertinib has shown a median survival of more than 38 months in stage 4 cancer patients, which is significantly better than traditional chemotherapy.

Immunotherapy: Using the Body’s Immune System

Another breakthrough in lung cancer treatment is immunotherapy, which helps the body’s immune system recognise and attack cancer cells.

Patients with high levels of a marker called PD-L1 on the biopsy may benefit from immunotherapy alone. Clinical trials have shown a median survival exceeding 2 years, and some patients remain alive beyond five years.

Compared to chemotherapy, these newer treatments often provide better survival and improved quality of life with minimal to no side effects.

The Most Important Message

Lung cancer is a serious disease, but early detection and modern treatments have greatly improved outcomes.

Key messages for the public include:

• Stop smoking — quitting significantly reduces risk.
• High-risk individuals should discuss LDCT screening with their lung specialist doctor.
• Persistent cough or suspicious symptoms should never be ignored.
• Early-stage lung cancer can often be cured.
• Even advanced lung cancer is treatable today, with many patients living longer and better lives.

Increasing awareness and encouraging early diagnosis can save many lives.

Conclusion:

Lung cancer is common but no longer a hopeless disease. As they became more widely known, screened quickly, and treated faster, the outcomes for many of these patients today are much better than ever. Early detection is highly treatable and new therapies such as targeted therapy, immunotherapy are enabling advanced-stage patients to live longer, better lives. The key step is never ignoring warning signs and avoiding tobacco exposure; see a doctor if at risk. This is like the saying early detection will help save lives, Nanjappa hospitals declared.

FAQs